Alzheimer Dis Assoc Disord

1. PACHI I, Evans AH, Loi SM, Eratne D, et al
   Odor Identification Testing Can Assist in the Clinical Distinction Between Psychiatric Disorders and Neurological/Neurodegenerative Disorders.
   Alzheimer Dis Assoc Disord. 2021;35:244-249.
   

   >> Share

   
   
2. KAUFMAN CS, Morris JK, Vidoni ED, Burns JM, et al
   Apolipoprotein E4 Moderates the Association Between Vascular Risk Factors and Brain Pathology.
   Alzheimer Dis Assoc Disord. 2021;35:223-229.
   

   >> Share

   
   
3. FRIZ AM, Benson C, Mullen S, Block L, et al
   Tailoring Research Recruitment for Acute Care Settings: Recommendations from People with Dementia and their Caregivers.
   Alzheimer Dis Assoc Disord. 2021;35:191-199.
   

   >> Share

   
   

   
   Alzheimers Dement

4. PLANCHE V, Bouteloup V, Mangin JF, Dubois B, et al
   Clinical relevance of brain atrophy subtypes categorization in memory clinics.
   Alzheimers Dement. 2021;17:641-652.
   

   >> Share

   
   
5. STAFFARONI AM, Asken BM, Casaletto KB, Fonseca C, et al
   Development and validation of the Uniform Data Set (v3.0) executive function composite score (UDS3-EF).
   Alzheimers Dement. 2021;17:574-583.
   

   >> Share

   
   
6. FANI L, Ahmad S, Ikram MK, Ghanbari M, et al
   Immunity and amyloid beta, total tau and neurofilament light chain: Findings from a community-based cohort study.
   Alzheimers Dement. 2021;17:446-456.
   

   >> Share

   
   
7. GRANOT-HERSHKOVITZ E, Tarraf W, Kurniansyah N, Daviglus M, et al
   APOE alleles' association with cognitive function differs across Hispanic/Latino groups and genetic ancestry in the study of Latinos-investigation of neurocognitive aging (HCHS/SOL).
   Alzheimers Dement. 2021;17:466-474.
   

   >> Share

   
   
8. KNOPMAN DS, Jones DT, Greicius MD
   Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019.
   Alzheimers Dement. 2021;17:696-701.
   

   >> Share

   
   
9. KULLER LH, Lopez OL
   ENGAGE and EMERGE: Truth and consequences?
   Alzheimers Dement. 2021;17:692-695.
   

   >> Share

   
   
10. BRAY MJC, Richey LN, Bryant BR, Krieg A, et al
    Traumatic brain injury alters neuropsychiatric symptomatology in all-cause dementia.
    Alzheimers Dement. 2021;17:686-691.
    

    >> Share

    
    
11. 
    Alzheimer's Disease Interventions: Implications of therapeutic promises amidst questions and doubts about clinically meaningful outcomes.
    Alzheimers Dement. 2021;17:1591-1594.
    

    >> Share

    
    
12. LI Y, Xiong C, Aschenbrenner AJ, Chang CH, et al
    Item response theory analysis of the Clinical Dementia Rating.
    Alzheimers Dement. 2021;17:534-542.
    

    >> Share

    
    
13. BOADA M, Lopez OL, Olazaran J, Nunez L, et al
    Neuropsychological, neuropsychiatric, and quality-of-life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study.
    Alzheimers Dement. 2021 Nov 2. doi: 10.1002/alz.12477.
    

    >> Share

    
    

    
    Am J Alzheimers Dis Other Demen

14. CHENG Y, Sun M, Wang F, Geng X, et al
    Identification of Hub Genes Related to Alzheimer's Disease and Major Depressive Disorder.
    Am J Alzheimers Dis Other Demen. 2021;36:15333175211046123.
    

    >> Share

    
    

    
    Am J Pathol

15. PROCTER TV, Williams A, Montagne A
    Interplay between Brain Pericytes and Endothelial Cells in Dementia.
    Am J Pathol. 2021;191:1917-1931.
    

    >> Share

    
    
16. ARBOLEDA-VELASQUEZ JF
    Safe and Effective Disease-Modifying Therapies for Small Blood Vessel Disease in the Brain.
    Am J Pathol. 2021;191:1852-1855.
    

    >> Share

    
    

    
    Am J Psychiatry

17. KUMAR A, Nemeroff CB, Cooper JJ, Widge A, et al
    Amyloid and Tau in Alzheimer's Disease: Biomarkers or Molecular Targets for Therapy? Are We Shooting the Messenger?
    Am J Psychiatry. 2021;178:1014-1025.
    

    >> Share

    
    
18. KALIN NH
    Adversity, Trauma, Suicide, and Alzheimer's Disease.
    Am J Psychiatry. 2021;178:985-987.
    

    >> Share

    
    

    
    Ann Neurol

19. SANDROCK A
    Letter Concerning Medicare Should Not Cover Aducanumab as a Treatment for Alzheimer's Disease by Moghavem, Henderson, and Greicius.
    Ann Neurol. 2021 Oct 23. doi: 10.1002/ana.26254.
    

    >> Share

    
    

    
    BMC Neurol

20. ZHU W, Li X, Li X, Wang H, et al
    The protective impact of education on brain structure and function in Alzheimer's disease.
    BMC Neurol. 2021;21:423.
    

    >> Share

    
    

    
    Curr Alzheimer Res

21. WATTMO C, Blennow K, Hansson O
    Cerebrospinal Fluid Biomarker Levels as Markers for Nursing Home Placement and Survival Time in Alzheimer's Disease.
    Curr Alzheimer Res. 2021 Oct 22. pii: CAR-EPUB-118547.
    

    >> Share

    
    
22. MIRZAEI N, Davis N, Chau TW, Sastre M, et al
    Astrocyte Reactivity in Alzheimer's Disease: Therapeutic Opportunities to Promote Repair.
    Curr Alzheimer Res. 2021 Oct 29. pii: CAR-EPUB-118626.
    

    >> Share

    
    

    
    Dement Geriatr Cogn Disord

23. KAO SL, Wang JH, Chen SC, Li YY, et al
    Impact of Comorbidity Burden on Cognitive Decline: A Prospective Cohort Study of Older Adults with Dementia.
    Dement Geriatr Cogn Disord. 2021;50:43-50.
    

    >> Share

    
    

    
    J Alzheimers Dis

24. SHOJAIE M, Tabarestani S, Cabrerizo M, DeKosky ST, et al
    PET Imaging of Tau Pathology and Amyloid-beta, and MRI for Alzheimer's Disease Feature Fusion and Multimodal Classification.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD210064. doi: 10.3233/JAD-210064.
    

    >> Share

    
    
25. HIN N, Newman M, Pederson S, Lardelli M, et al
    Iron Responsive Element-Mediated Responses to Iron Dyshomeostasis in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD210200. doi: 10.3233/JAD-210200.
    

    >> Share

    
    
26. RUSANEN M, Selander T, Karkkainen V, Koivisto A, et al
    The Positive Effects of Pet Ownership on Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD210557. doi: 10.3233/JAD-210557.
    

    >> Share

    
    
27. KARAMI V, Nittari G, Traini E, Amenta F, et al
    An Optimized Decision Tree with Genetic Algorithm Rule-Based Approach to Reveal the Brain's Changes During Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2021 Oct 23. pii: JAD210626. doi: 10.3233/JAD-210626.
    

    >> Share

    
    
28. SCHULTZ B, Taday J, Menezes L, Cigerce A, et al
    Calpain-Mediated Alterations in Astrocytes Before and During Amyloid Chaos in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD215182. doi: 10.3233/JAD-215182.
    

    >> Share

    
    
29. TORRES AK, Jara C, Park-Kang HS, Polanco CM, et al
    Synaptic Mitochondria: An Early Target of Amyloid-beta and Tau in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD215139. doi: 10.3233/JAD-215139.
    

    >> Share

    
    
30. JEONG HJ, Lee YM, Park JM, Lee BD, et al
    Reduced Thickness of the Anterior Cingulate Cortex as a Predictor of Amnestic-Mild Cognitive Impairment Conversion to Alzheimer's Disease with Psychosis.
    J Alzheimers Dis. 2021 Oct 26. pii: JAD215005. doi: 10.3233/JAD-215005.
    

    >> Share

    
    
31. BJORKLI C, Louet C, Flo TH, Hemler M, et al
    In Vivo Microdialysis in Mice Captures Changes in Alzheimer's Disease Cerebrospinal Fluid Biomarkers Consistent with Developing Pathology.
    J Alzheimers Dis. 2021 Oct 29. pii: JAD210715. doi: 10.3233/JAD-210715.
    

    >> Share

    
    

    
    J Neurol

32. SCHUMACHER J, Taylor JP, Hamilton CA, Firbank M, et al
    Functional connectivity in mild cognitive impairment with Lewy bodies.
    J Neurol. 2021;268:4707-4720.
    

    >> Share

    
    
33. SANTORO JD, Pagarkar D, Chu DT, Rosso M, et al
    Neurologic complications of Down syndrome: a systematic review.
    J Neurol. 2021;268:4495-4509.
    

    >> Share

    
    

    
    Nat Rev Neurosci

34. PADMANABHAN P, Kneynsberg A, Gotz J
    Super-resolution microscopy: a closer look at synaptic dysfunction in Alzheimer disease.
    Nat Rev Neurosci. 2021 Nov 1. pii: 10.1038/s41583-021-00531.
    

    >> Share

    
    

    
    Nature

35. BERG J, Sorensen SA, Ting JT, Miller JA, et al
    Human neocortical expansion involves glutamatergic neuron diversification.
    Nature. 2021;598:151-158.
    

    >> Share

    
    

    
    Nervenarzt

36. FROLICH L, Hausner L
    [Disease-modifying treatment approaches for Alzheimer's disease].
    Nervenarzt. 2021 Nov 4. pii: 10.1007/s00115-021-01222.
    

    >> Share

    
    

    
    Neurobiol Dis

37. BIYONG ESSI F, Cyntia T, Manon L, Vicky C, et al
    Role of Retinoid X Receptors (RXRs) and dietary vitamin A in Alzheimer's disease: Evidence from clinicopathological and preclinical studies.
    Neurobiol Dis. 2021 Nov 1:105542. doi: 10.1016/j.nbd.2021.105542.
    

    >> Share

    
    
38. KOW RL, Strovas TJ, McMillan PJ, Jacobi AM, et al
    Distinct Poly(A) nucleases have differential impact on sut-2 dependent tauopathy phenotypes.
    Neurobiol Dis. 2021;147:105148.
    

    >> Share

    
    
39. ALCALA-VIDA R, Awada A, Boutillier AL, Merienne K, et al
    Epigenetic mechanisms underlying enhancer modulation of neuronal identity, neuronal activity and neurodegeneration.
    Neurobiol Dis. 2021;147:105155.
    

    >> Share

    
    

    
    Neurochem Res

40. JIANG P, Chen L, Xu J, Liu W, et al
    Neuroprotective Effects of Rhynchophylline Against Abeta1-42-Induced Oxidative Stress, Neurodegeneration, and Memory Impairment Via Nrf2-ARE Activation.
    Neurochem Res. 2021;46:2439-2450.
    

    >> Share

    
    

    
    Neuropsychology

41. ZABBERONI S, Carlesimo GA, Perri R, Barban F, et al
    Implicit prototype learning in patients with memory deficit: Evidence from a study with Alzheimer's disease patients.
    Neuropsychology. 2021 Nov 4. pii: 2022-00064-001. doi: 10.1037/neu0000772.
    

    >> Share

    
    

    
    PLoS One

42. WU Y, Whittaker HT, Noy S, Cleverley K, et al
    The effects of Cstb duplication on APP/amyloid-beta pathology and cathepsin B activity in a mouse model.
    PLoS One. 2021;16:e0242236.
    

    >> Share

    
    
43. BAILEY DK, Clark W, Kosman DJ
    The iron chelator, PBT434, modulates transcellular iron trafficking in brain microvascular endothelial cells.
    PLoS One. 2021;16:e0254794.
    

    >> Share

    
    
44. NOGUCHI-SHINOHARA M, Koike M, Morise H, Kudo K, et al
    MEG activity of the dorsolateral prefrontal cortex during optic flow stimulations detects mild cognitive impairment due to Alzheimer's disease.
    PLoS One. 2021;16:e0259677.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

45. GHOSH U, Yau WM, Collinge J, Tycko R, et al
    Structural differences in amyloid-beta fibrils from brains of nondemented elderly individuals and Alzheimer's disease patients.
    Proc Natl Acad Sci U S A. 2021;118.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share